UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease

Alimentary pharmacology & therapeutics, 2012-06, Vol.35 (11), p.1279-1289

2012

Volltextzugriff (PDF)

Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis

Alimentary pharmacology & therapeutics, 1998-09, Vol.12 (9), p.865-872

1998

Volltextzugriff (PDF)

Efficacy and Tolerability of Pantoprazole Compared with Misoprostol for the Prevention of NSAID-Related Gastrointestinal Lesions and Symptoms in Rheumatic Patients

Digestion, 2003-01, Vol.68 (4), p.198-208

2003

Volltextzugriff (PDF)

Twenty‐four‐hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole

Alimentary pharmacology & therapeutics, 1996-06, Vol.10 (3), p.359-366

1996

Volltextzugriff (PDF)

Relative Efficacies of Gastric Proton Pump Inhibitors: Their Clinical and Pharmacological Basis

Pharmacology, 1999-08, Vol.59 (2), p.57-77

1999

Volltextzugriff (PDF)

Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease

European journal of gastroenterology & hepatology, 2000-04, Vol.12 (4), p.425-432

2000

Volltextzugriff (PDF)

P151 Tiotropium Respimat® add-on therapy reduces exacerbation risk in patients with moderate or severe symptomatic asthma, independent of TH2 status: Abstract P151 Table 1

Thorax, 2015-12, Vol.70 (Suppl 3), p.A152-A153

2015

Volltextzugriff (PDF)

P151 Tiotropium Respimat® add-on therapy reduces exacerbation risk in patients with moderate or severe symptomatic asthma, independent of TH2 status

Thorax, 2015-12, Vol.70 (Suppl 3), p.A152

2015

Volltextzugriff (PDF)

Pharmacokinetics of pantoprazole in man

International journal of clinical pharmacology and therapeutics, 1996-05, Vol.34 (5), p.185

1996

Volltextzugriff (PDF)

Pharmacokinetics of pantoprazole in man

International journal of clinical pharmacology and therapeutics, 1996-05, Vol.34 (1 Suppl), p.S7

1996

Volltextzugriff (PDF)

Pharmacokinetics of pantoprazole in patients with end-stage renal failure

Nephrology, dialysis, transplantation, 1998-05, Vol.13 (5), p.1189-1193

1998

Volltextzugriff (PDF)

Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine

Methods and Findings in Experimental and Clinical Pharmacology, 2005, Vol.27 (1), p.25-29

2005

Volltextzugriff (PDF)

Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study

Journal of clinical gastroenterology, 1995-04, Vol.20 (3), p.192-195

1995

Volltextzugriff (PDF)

Letter: the effects of overlapping symptoms on the response to PPI therapy in GERD - authors' reply

Alimentary pharmacology & therapeutics, 2012-07, Vol.36 (2), p.207-208

2012

Volltextzugriff (PDF)

Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects

European journal of gastroenterology & hepatology, 1996-09, Vol.8 (9), p.915

1996

Volltextzugriff (PDF)

Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole

Alimentary pharmacology & therapeutics, 1998-10, Vol.12 (10), p.1027-1032

1998

Volltextzugriff (PDF)

Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection

Alimentary pharmacology & therapeutics, 1999-01, Vol.13 (1), p.27-34

1999

Volltextzugriff (PDF)

Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration

International journal of clinical pharmacology and therapeutics, 1994-01, Vol.32 (1), p.44

1994

Volltextzugriff (PDF)

Pantoprazole therapy in the long-term management of severe acid peptic disease Clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies

The American journal of gastroenterology, 2001-06, Vol.96 (6), p.1767-1776

2001

Volltextzugriff (PDF)

Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration

International journal of clinical pharmacology and therapeutics, 1996-05, Vol.34 (1 Suppl), p.S18

1996

Volltextzugriff (PDF)

PANTOPRAZOLE AND 24‐HOUR INTRAGASTRIC ACIDITY

Alimentary pharmacology & therapeutics, 1993-02, Vol.7 (1), p.115-115

1993

Volltextzugriff (PDF)

Eltenac, a new anti-inflammatory and analgesic drug for horses: clinical aspects

Journal of veterinary pharmacology and therapeutics, 1991-06, Vol.14 (2), p.193-199

1991

Volltextzugriff (PDF)

Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers

Zeitschrift für Gastroenterologie, 1990-09, Vol.28 (9), p.443

1990

Volltextzugriff (PDF)

Pantoprazole therapy in the long-term management of severe acid peptic disease: Clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies

The American journal of gastroenterology, 2001-06, Vol.96 (6), p.1767-1776

2001

Volltextzugriff (PDF)

Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH

European journal of gastroenterology & hepatology, 1997-06, Vol.9 (6), p.599-602

1997

Volltextzugriff (PDF)

1 – 25 von 1.044

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(876)
Mit Volltextzugriff
(850)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.008)
Deutsch
(26)
Russisch
(5)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(658)
Physical Sciences
(480)
Physics
(290)
Exact Sciences And Technology
(183)
Astronomy & Astrophysics
(176)
Technology
(153)
Life Sciences & Biomedicine
(130)
Physics, Applied
(112)
Magnetic Fields
(100)
Earth, Ocean, Space
(93)
Physics, Fluids & Plasmas
(91)
70 Plasma Physics And Fusion Technology
(87)
Humans
(87)
Mars
(86)
Solar Wind
(82)
Engineering
(81)
Male
(69)
Animals
(68)
Tokamak Devices
(64)
Instruments & Instrumentation
(62)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease

Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis

Efficacy and Tolerability of Pantoprazole Compared with Misoprostol for the Prevention of NSAID-Related Gastrointestinal Lesions and Symptoms in Rheumatic Patients

Twenty‐four‐hour intragastric pH profiles and pharmacokinetics following single and repeated oral administration of the proton pump inhibitor pantoprazole in comparison to omeprazole

Relative Efficacies of Gastric Proton Pump Inhibitors: Their Clinical and Pharmacological Basis

Pantoprazole 20 mg is an effective maintenance therapy for patients with gastro-oesophageal reflux disease

P151 Tiotropium Respimat® add-on therapy reduces exacerbation risk in patients with moderate or severe symptomatic asthma, independent of TH2 status: Abstract P151 Table 1

P151 Tiotropium Respimat® add-on therapy reduces exacerbation risk in patients with moderate or severe symptomatic asthma, independent of TH2 status

Pharmacokinetics of pantoprazole in man

Pharmacokinetics of pantoprazole in man

Pharmacokinetics of pantoprazole in patients with end-stage renal failure

Pharmacodynamic effects of 3-day intravenous treatment with pantoprazole or ranitidine after 10 days of oral ranitidine

Comparative trial of pantoprazole and ranitidine in the treatment of reflux esophagitis. Results of a German multicenter study

Letter: the effects of overlapping symptoms on the response to PPI therapy in GERD - authors' reply

Intragastric pH and serum gastrin during administration of different doses of pantoprazole in healthy subjects

Equipotent inhibition of gastric acid secretion by equal doses of oral or intravenous pantoprazole

Effects of pumaprazole (BY841), a novel reversible proton pump antagonist, and of omeprazole, on intragastric acidity before and after cure of Helicobacter pylori infection

Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration

Pantoprazole therapy in the long-term management of severe acid peptic disease Clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies

Dose linearity of the pharmacokinetics of the new H+/K(+)-ATPase inhibitor pantoprazole after single intravenous administration

PANTOPRAZOLE AND 24‐HOUR INTRAGASTRIC ACIDITY

Eltenac, a new anti-inflammatory and analgesic drug for horses: clinical aspects

Pentagastrin-stimulated gastric acid secretion and pharmacokinetics following single and repeated intravenous administration of the gastric H+, K(+)-ATPase-inhibitor pantoprazole (BY1023/SK&F96022) in healthy volunteers

Pantoprazole therapy in the long-term management of severe acid peptic disease: Clinical efficacy, safety, serum gastrin, gastric histology, and endocrine cell studies

Morning and evening administration of pantoprazole: a study to compare the effect on 24-hour intragastric pH

Suchergebnisse filtern